• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌耐药蛋白(BCRP/ABCG2)在癌症药物耐药中的作用。

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

机构信息

University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA.

出版信息

Biochem Pharmacol. 2012 Apr 15;83(8):1084-103. doi: 10.1016/j.bcp.2012.01.002. Epub 2012 Jan 11.

DOI:10.1016/j.bcp.2012.01.002
PMID:22248732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3307098/
Abstract

Since cloning of the ATP-binding cassette (ABC) family member breast cancer resistance protein (BCRP/ABCG2) and its characterization as a multidrug resistance efflux transporter in 1998, BCRP has been the subject of more than two thousand scholarly articles. In normal tissues, BCRP functions as a defense mechanism against toxins and xenobiotics, with expression in the gut, bile canaliculi, placenta, blood-testis and blood-brain barriers facilitating excretion and limiting absorption of potentially toxic substrate molecules, including many cancer chemotherapeutic drugs. BCRP also plays a key role in heme and folate homeostasis, which may help normal cells survive under conditions of hypoxia. BCRP expression appears to be a characteristic of certain normal tissue stem cells termed "side population cells," which are identified on flow cytometric analysis by their ability to exclude Hoechst 33342, a BCRP substrate fluorescent dye. Hence, BCRP expression may contribute to the natural resistance and longevity of these normal stem cells. Malignant tissues can exploit the properties of BCRP to survive hypoxia and to evade exposure to chemotherapeutic drugs. Evidence is mounting that many cancers display subpopulations of stem cells that are responsible for tumor self-renewal. Such stem cells frequently manifest the "side population" phenotype characterized by expression of BCRP and other ABC transporters. Along with other factors, these transporters may contribute to the inherent resistance of these neoplasms and their failure to be cured.

摘要

自 1998 年克隆 ATP 结合盒(ABC)家族成员乳腺癌耐药蛋白(BCRP/ABCG2)并将其鉴定为多药耐药外排转运蛋白以来,BCRP 已成为两千多篇学术文章的主题。在正常组织中,BCRP 作为一种防御机制,对抗毒素和外源性物质,在肠道、胆小管、胎盘、血睾和血脑屏障中表达,促进排泄并限制潜在毒性底物分子的吸收,包括许多癌症化疗药物。BCRP 还在血红素和叶酸稳态中发挥关键作用,这有助于正常细胞在缺氧条件下存活。BCRP 表达似乎是某些正常组织干细胞的特征,这些干细胞被称为“侧群细胞”,它们在流式细胞分析中通过其排除 BCRP 底物荧光染料 Hoechst 33342 的能力来识别。因此,BCRP 表达可能有助于这些正常干细胞的自然耐药性和长寿性。恶性组织可以利用 BCRP 的特性来在缺氧环境中存活,并逃避化疗药物的暴露。越来越多的证据表明,许多癌症显示出负责肿瘤自我更新的干细胞亚群。这些干细胞经常表现出 BCRP 和其他 ABC 转运蛋白表达的“侧群”表型。这些转运蛋白与其他因素一起,可能导致这些肿瘤的固有耐药性及其无法治愈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9458/3307098/b0b45ba171d9/nihms354352f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9458/3307098/93ffce25e822/nihms354352f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9458/3307098/b0b45ba171d9/nihms354352f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9458/3307098/93ffce25e822/nihms354352f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9458/3307098/b0b45ba171d9/nihms354352f2.jpg

相似文献

1
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.乳腺癌耐药蛋白(BCRP/ABCG2)在癌症药物耐药中的作用。
Biochem Pharmacol. 2012 Apr 15;83(8):1084-103. doi: 10.1016/j.bcp.2012.01.002. Epub 2012 Jan 11.
2
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.乳腺癌耐药蛋白(BCRP/ABCG2):其在多药耐药中的作用及其基因表达的调控
Chin J Cancer. 2012 Feb;31(2):73-99. doi: 10.5732/cjc.011.10320. Epub 2011 Nov 18.
3
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).由乳腺癌耐药蛋白BCRP(ABCG2)介导的多药耐药。
Oncogene. 2003 Oct 20;22(47):7340-58. doi: 10.1038/sj.onc.1206938.
4
Role of the breast cancer resistance protein (ABCG2) in drug transport.乳腺癌耐药蛋白(ABCG2)在药物转运中的作用。
AAPS J. 2005 May 11;7(1):E118-33. doi: 10.1208/aapsj070112.
5
Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).人乳腺癌耐药蛋白(BCRP/ABCG2)的结构与功能。
Curr Drug Metab. 2010 Sep;11(7):603-17. doi: 10.2174/138920010792927325.
6
Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.由半ATP结合盒转运蛋白ABCG2介导的癌症化疗中的多药耐药性和外源性物质保护。
Curr Med Chem Anticancer Agents. 2004 Jan;4(1):31-42. doi: 10.2174/1568011043482205.
7
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.多药耐药蛋白:P-糖蛋白、多药耐药相关蛋白1、多药耐药相关蛋白2和乳腺癌耐药蛋白(ABCG2)在组织防御中的作用
Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. doi: 10.1016/j.taap.2004.10.012.
8
Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.乳腺癌耐药蛋白(BCRP/ABCG2)在药物转运中的作用——最新进展
AAPS J. 2015 Jan;17(1):65-82. doi: 10.1208/s12248-014-9668-6. Epub 2014 Sep 19.
9
Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells.褪黑素诱导 ABCG2/BCRP 启动子甲基化作为克服脑肿瘤干细胞多药耐药的新机制。
Br J Cancer. 2013 May 28;108(10):2005-12. doi: 10.1038/bjc.2013.188. Epub 2013 Apr 30.
10
Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.乳腺癌耐药蛋白在药代动力学及药物相互作用中的研究
Expert Opin Drug Metab Toxicol. 2005 Dec;1(4):595-611. doi: 10.1517/17425255.1.4.595.

引用本文的文献

1
Enhancement of doxorubicin efficacy by diosmetin through DNA damage accumulation and P-glycoprotein inhibition in breast cancer cells.香叶木素通过在乳腺癌细胞中积累DNA损伤和抑制P-糖蛋白增强阿霉素疗效
Sci Rep. 2025 Aug 21;15(1):30814. doi: 10.1038/s41598-025-16681-3.
2
Molecular chameleons adaptability in target binding.分子变色龙在靶标结合中的适应性。
Struct Dyn. 2025 Aug 13;12(4):044701. doi: 10.1063/4.0000757. eCollection 2025 Jul.
3
The application of liver cancer organoids in tumour precision medicine: A comprehensive review.

本文引用的文献

1
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.阿糖胞苷联合马来酸氨苯砜或柔红霉素作为二线急性髓系白血病诱导治疗的 III 期开放性随机研究。
J Clin Oncol. 2015 Apr 10;33(11):1252-7. doi: 10.1200/JCO.2014.57.0952. Epub 2015 Mar 2.
2
Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model.Abcg2 表达标志着小鼠后代追踪模型中多个器官的组织特异性干细胞。
Stem Cells. 2012 Feb;30(2):210-21. doi: 10.1002/stem.1002.
3
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
肝癌类器官在肿瘤精准医学中的应用:一项综述
ILIVER. 2025 Jul 5;4(3):100179. doi: 10.1016/j.iliver.2025.100179. eCollection 2025 Sep.
4
Elevated BCRP Transporter and Altered NF-кB Pathway Mediate Zoledronic Acid Resistance in MCF-7 Cells.BCRP转运蛋白升高和NF-кB信号通路改变介导MCF-7细胞对唑来膦酸的耐药性。
J Biochem Mol Toxicol. 2025 Jul;39(7):e70397. doi: 10.1002/jbt.70397.
5
Isoetin from Isoetaceae Exhibits Superior Pentatransferase Inhibition in Breast Cancer: Comparative Computational Profiling with FDA-Approved Tucatinib.来自卷柏科的异黄腐醇在乳腺癌中表现出卓越的五转移酶抑制作用:与美国食品药品监督管理局批准的图卡替尼的比较计算分析
Pharmaceuticals (Basel). 2025 Apr 30;18(5):662. doi: 10.3390/ph18050662.
6
Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence.胰高血糖素样肽1受体激动剂与癌症风险:通过机制理解和临床证据推动精准医学发展
Biomark Res. 2025 Mar 27;13(1):50. doi: 10.1186/s40364-025-00765-3.
7
Ferric Ammonium Citrate Reduces Claudin-5 Abundance and Function in Primary Mouse Brain Endothelial Cells.柠檬酸铁铵降低原代小鼠脑内皮细胞中Claudin-5的丰度和功能。
Pharm Res. 2025 Feb;42(2):319-334. doi: 10.1007/s11095-025-03826-2. Epub 2025 Feb 12.
8
Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting restorative regimens.上皮-间质转化在乳腺癌转移中的可鄙作用:展示恢复性方案。
Cancer Pathog Ther. 2024 Jan 12;3(1):30-47. doi: 10.1016/j.cpt.2024.01.001. eCollection 2025 Jan.
9
Ferroptosis Inducers Erastin and RSL3 Enhance Adriamycin and Topotecan Sensitivity in ABCB1/ABCG2-Expressing Tumor Cells.铁死亡诱导剂埃拉斯汀和RSL3增强表达ABCB1/ABCG2的肿瘤细胞对阿霉素和拓扑替康的敏感性。
Int J Mol Sci. 2025 Jan 14;26(2):635. doi: 10.3390/ijms26020635.
10
Elucidating the binding specificity of interactive compounds targeting ATP-binding cassette subfamily G member 2 (ABCG2).阐明靶向ATP结合盒亚家族G成员2(ABCG2)的相互作用化合物的结合特异性。
Mol Divers. 2025 Jan 9. doi: 10.1007/s11030-024-11078-2.
乳腺癌耐药蛋白(BCRP/ABCG2):其在多药耐药中的作用及其基因表达的调控
Chin J Cancer. 2012 Feb;31(2):73-99. doi: 10.5732/cjc.011.10320. Epub 2011 Nov 18.
4
The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system.ABC 膜转运蛋白 ABCG2 可阻止 FAAH 抑制剂 URB937 进入中枢神经系统。
Pharmacol Res. 2011 Oct;64(4):359-63. doi: 10.1016/j.phrs.2011.07.001. Epub 2011 Jul 7.
5
Detection of hematopoietic stem cells by flow cytometry.通过流式细胞术检测造血干细胞。
Methods Cell Biol. 2011;103:21-30. doi: 10.1016/B978-0-12-385493-3.00002-4.
6
Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.鉴定和表征调节小鼠肠道中Bcrp1/Abcg2表达的主要可变启动子。
Biochim Biophys Acta. 2011 Jul;1809(7):295-305. doi: 10.1016/j.bbagrm.2011.06.004. Epub 2011 Jun 28.
7
Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.上调乳腺癌耐药蛋白通过 MCF7 乳腺癌细胞中的 PI3K/Akt 和核因子-κB 信号通路在 HER2 介导的化疗耐药中发挥作用。
Acta Biochim Biophys Sin (Shanghai). 2011 Aug;43(8):647-53. doi: 10.1093/abbs/gmr050. Epub 2011 Jun 28.
8
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.c-MYC 癌蛋白决定慢性髓性白血病 CD34+造血祖细胞中 ATP 结合盒转运蛋白基因的转录谱。
Mol Cancer Res. 2011 Aug;9(8):1054-66. doi: 10.1158/1541-7786.MCR-10-0510. Epub 2011 Jun 21.
9
Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.鉴定在儿科急性巨核细胞白血病中表达的新型组织特异性 ABCG2 启动子。
Leuk Res. 2011 Oct;35(10):1321-9. doi: 10.1016/j.leukres.2011.05.004.
10
ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.ABCG2 是 hedgehog 信号的直接转录靶标,并且与弥漫性大 B 细胞淋巴瘤中的基质诱导的药物耐受性有关。
Oncogene. 2011 Dec 8;30(49):4874-86. doi: 10.1038/onc.2011.195. Epub 2011 May 30.